India's Pharma Sector Faces U.S. Tariff Challenge

The U.S. is planning to add big taxes, called tariffs, on certain medicines from other countries, specifically those with brand names or patents.

These tariffs, which will start in 2025, are meant to encourage drug companies to make their products in America.

India, a major supplier of medicine to the U.S., is concerned because this could hurt their business.

The tariffs might make the cost of drugs go up and could cause shortages in the U.S. However, some Indian companies may try to make their own brands or set up factories in other countries to sell their products.